Postoperative endophthalmitis: Optimal management and the role and timing of vitrectomy surgery

Eye

Volumn 22, Issue 10, 2008, Pages 1290-1300

  Maguire, J I ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIMETABOLITE; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; DEXAMETHASONE; FLUOROURACIL; LEVOFLOXACIN; MITOMYCIN C; MOXIFLOXACIN; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RANIBIZUMAB; RIFABUTIN; TRIAMCINOLONE; VANCOMYCIN;

ADJUVANT THERAPY; ANTIBIOTIC PROPHYLAXIS; CANDIDA PARAPSILOSIS; CATARACT EXTRACTION; CLINICAL TRIAL; CONFERENCE PAPER; CORNEA SURGERY; DISEASE CLASSIFICATION; ENDOPHTHALMITIS; FILTERING OPERATION; HUMAN; INCIDENCE; INTRAOCULAR HYPOTENSION; MEDLINE; NONHUMAN; PREOPERATIVE EDUCATION; PROPIONIBACTERIUM; REFRACTIVE SURGERY; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; RETINA MACULOPATHY; RISK REDUCTION; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL TECHNIQUE; VITRECTOMY; VITREOUS OPACITY;

EID: 54249144417     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.51     Document Type: Conference Paper

References (56)

1. Lemley CA, Han DP. Endophthalmitis: A review of current evaluation and management. Retina 2007; 27(6): 662-680.
2. Mamalis N, Kearsley L, Brinton E. Postoperative endophthalmitis. Curr Opin Ophthalmol 2002; 13(1): 14-18.
3. Kressloff MS, Castellarin A, Zarbin MA. Endophthalmitis. Survey Ophthalmol 1998; 43: 193-224.
4. Aaberg TM, Flynn HW, Schiffman J, Newtown J. Nosocomial acute-onset postoperative endophthalmitis survey. A 10 year review of incidence and outcomes. Ophthalmology 1998; 105(6): 1004-1010.
5. Cooper BA, Holekamp NM, Bohigiap G, Thompson PA. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. Am J Ophthalmol 2003; 136: 300-305.
6. Somani S, Grinbaum A, Slomovic AR. Postoperative endophthalmitis: incidence, predisposing surgery, clinical course and outcome. Can J Ophthalmol 1997; 32(5): 303-310.
7. Flynn Jr HW, Scott IU, Brod RD, Han DP. Current management of endophthalmitis. Int Ophthalmol Clin 2004; 44(4): 115-137.
8. Endophthalmitis Vitrectomy Study Group. Results of Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995; 113: 1479-1496.
9. Javitt JC, Street DA, Tielsch JM, Wang Q, Kolb MM, Schien O et al. National outcomes of cataract extraction; retinal detachment and endophthalmitis after outpatient cataract surgery. Ophthalmology 1994; 101: 100-105.
10. Schmitz S, Dick HB, Krummenhauer F, Pfeiffer N. Endophthalmitis in cataract surgery results of a German survey. Ophthalmol 1999; 106: 1869-1877.
11. Taban M, Behrens A, Newcomb RL, Nobe NY, Saedi G, Sweet PM et al. Acute endophthalmitis following cataract surgery: A systematic review of the literature. Arch Ophthalmol 2005; 123: 613-620.
12. Barry P, Seal DV, Gettinby G, Lees F, Peterson M, Revie CW et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. J Cataract Refract Surg 2006; 32 407-410.
13. Nagaki Y, Hayasaka S, Kadoi C, Matsumoto M, Yanagisawa S, Watanabe K et al. Bacterial endophthalmitis alter small-incision cataract surger. Effect of incision placement and intraocular lens type. J Cataract Refract Surg 2003; 136: 300-305.
14. McDonnnell PJ, Taban M, Sarabaya M, Rao B, Zhang J, Schiffman R et al Dynamic morphology of dear corneal cataract incisions. Ophthalmology 2003; 110: 2342-2348.
15. Wallin T, Parker J, Jin Y, Kefalopoulos G, Oslon RJ. Cohort study of 27 eyes of endophthalmitis at a single institution. J Cataract Refract Surg 2006; 31: 735-741.
16. Sharma T, Chen SD, Salmon JF. Bleb-associated endophthalmitis. Ophthalmology 2005; 112(6): 1168.
17. Busbee BG. Update on treatment strategies for bleb-associated endophthalmitis. Curr Opin Ophthalmol 2005; 16(3): 170-174.
18. Ayyla Rs, Bellows AR, Thomas JV, Hutchinson BT. Bleb infections: clinically different courses of 'blebitis' and endophthalmitis. Oph Surg and Lasers 1997; 28(6): 452-460.
19. Parrish R, Minckler D. 'Late endophthalmitis' - filtering surgery time bomb? Ophthalmology 1996; 103: 1167-1168.
20. Greenfield DS, Suner IJ, Miller MP, Kangas TA, Palmberg PF, Flynn HW. Endophthalmitis after filtering surgery with mitomycin. Arch ophthalmol 1996; 114(8): 943-949.
21. Song A, Scott IU, Flynn Jr HW, Budenz DL. Delayed-onset bleb-associated endophthalmitis: Clinical features and visual acuity outcomes. Ophthalmology 2002; 109(5): 985-991.
22. Busbee BG, Recchia FM, Kaiser R, Nagra P, Rosenblatt B, Pearlman RB. Bleb-associated endophthalmitis: Clinical characteristics and visual outcomes. Ophthalmology 2004; 111: 1495-1503.
23. Eifrig CW, Scott IU, Flynn Jr HW, Smiddy WE, Newton J. Endophthalmitis after pars plana vitrectomy: Incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol 2004; 138(5): 799-802.
24. Kunnimoto D, Kaiser R. Incidence of endophthalmitis after 20- and 25-gauge vitrectomy. Ophthalmology 2007; 114: 2133-2137.
25. Jager RD, Aiello LP, Patel SC, Cunningham Jr ET. Risks of intravitreous injection: A comprehensive review. Retina 2004; 24: 676-698.
26. Aiello LP, Brucker AJ, Chang S, Cunningham Jr ET, D'Amico DJ, Flynn Jr HW et al. Evolving guidelines for intravitreous injections. Retina 2004; 24: S3-S19.
27. Lanzetta P. Combined safety of intravitreal ranibizumab in two phase III studies of choroidal neovascularization secondary to age-related macular degeneration. Program and abstracts of the 24th Annual American Society of Retina Specialists and 6th Annual European Vitreoretinal Society Meeting; September 9-13, 2006; Cannes, France 2006.
28. Sakamoto T, Enaida H, Kubota T, Nakahara M, Yamakiri K, Yamashita T et al. Incidence of acute endophthalmitis after triamcinolone-assisted pars plana vitrectomy. Am J Ophthalmol 2004; 138(1): 137-138.
29. Yuen HK, Chan CK, Lam D. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2004; 137 (6): 1166.
30. Speaker MG. How to head off endophthalmitis. Review Ophtalmol 2000; 7: 74-79.
31. Mendivil SA, Mendivil MP. The effect of topical povidone-iodine, intraocular vancomycin, or both on aqueous humor cultures at the time of cataract surgery. Am J Ophthalmol 2001; 131: 293-300.
32. Isenberg S, Apt L, Yoshimri R. Chemical preparation of the eye in ophthalmic surgery IV. Comparison of povidone-iodine on the conjunctiva with prophylactic antibiotic. Arch Ophthalmol 1985; 103: 1340-1342.
33. Isenberg S, Apt L, Yoshimri R. Chemical preparation of the eye in ophthalmic surgery III. Effect of povidone-iodine on the conjunctiva. Arch Ophthalmol 1984; 102: 728-729.
34. Hariprasad SM, Blinder KJ, Shah GK, Apte RS, Rosenblatt B, Holekamp NM et al. Penetration pharmacokinetics of topically administered 0.5% moxifloxacin ophthalmic solution in human aqueous and vitreous. Arch Ophthalmol 2005; 123(1): 39-44.
35. Moshirfar M, Felz V, Vitale AT, Wegelin JA, Bassavanthappa S, Wolsley DH. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones. A retrospective observational case series. Ophthalmology 2007; 114: 686-691.
36. Doft BH. The Endophthalmitis Vitrectomy Study. Arch Ophthalmol 1991; 109: 487-489.
37. Doft BH, Kelsey SF, Wisniewski SR. Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy Study. Ophtalmology 1998; 105: 707-716.
38. Kuhn F, Gini G. Ten years after. Are findings of the Endophthalmitis Vitrectomy Study still relevant today? Graefes Arch Clin Exp Ophthalmol 2005; 243: 1197-1199.
39. Siddiqui F, Crippen C, Hutnik CM. Do we heed the Endophthalmitis Vitrectomy Study in Canada? Can J Ophthalmol 2002; 37(7): 395-398.
40. Doft BH, Wisniewski SP, Kelsey SF, Fitzgerald SG, Endophthalmitis Vitrectorny Study Group. Diabetes and postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 2001; 119 (5); 650-656.
41. Enzenauer RW. Diabetes and the EVS: A different interpretation of the results. Arch Ophthalmol 2002; 120(2): 231-233.
42. Doft BH, Wisniewski SP, Kelsey SF, Groer-Fitzgerald S, Endophthalmitis Vitrectomy Study Group. Diabetes and postcataract extraction endophthalmitis. Curr Opin Ophthalmol 2002; 13(3): 147-151.
43. Sternberg Jr P, Martin DF. Management of endophthalmitis in the post-Endophthalmitis Vitrectomy Study era. Arch Ophthalmol 2001; 119(5): 754-755.
44. Durand ML. The post-Endophthalmitis Vitrectomy Study era. Arch Ophthalmol 2002; 120(2): 233-234.
45. Kuhn F, Gini G. Vitrectomy for endophthalmitis. Ophthalmology 2006; 113(4): 714.
46. Doft BM, Kelsey SF, Wisniewski SR. Retinal detachment in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol 2000; 118: 1661-1665.
47. Enzenauer RW, Biderman M. Retinal detachment and culture-proven bacterial endophthalmitis in the EVS. Arch Ophthalmol 2002; 120 2): 230-231.
48. De Smet MD, Carlborg EA. Managing severe endophthalmitis with the use of an endoscope. Retina 2005; 25(8): 976-980.
49. Ng JQ, Morlet N, Pearman JW, Constable IJ, McAllister IL, Kennedy CJ, et al., Team EPSWA. Management and outcomes of postoperative endophthalmitis since the Endophthalmitis Vitrectomy Study: The Endophthalmitis Population Study of Western Australia (EPSWA)'s fifth report. Ophthalmology 2005; 112(7): 1199-1206.
50. Miller D, Flynn PM, Scott IU, Alfonso EC, Flynn Jr HW. In vitro fluoroquinolone resistance in staphylococcus endophthalmitis isolates. Arch Ophthalmol 2006; 124: 479-483.
51. Hariprasad SM, Shah GK, Mieler WF, Feiner L, Blinder KJ, Holekamp NM et al. Vitreous and aqueous penetration of orally administered moxifloxacin in humans. Arch Ophthalmol 2006; 124(2): 178-182.
52. Aldave AJ, Stein JD, Deramo VA, Shah GK, Fischer DH, Maguire JI. Ophthalmology 1999; 106(12): 2395-2401.
53. Kampik A, Kenyon KR, Michels RG, Green WR, de la Cruz ZC. Epiretinal and vitreous membranes: Comparative study of 56 cases. Arch Ophthalmol 1980; 90: 797-809.
54. Wisniewski SP, Capone A, Kelsey SF, Groer-Fitzgerald S, Lambert HM, Doft BH. Characteristics after cataract extraction or secondary lens implantation among. patients screened for the Endophthalmitis Vitrectomy Study. Ophthalmology 2000; 107(7): 1274-1282.
55. Tsai YY, Tseng SH. Risk factors in endophthalmitis leading to evisceration or enucleation. Ophthalmic Surg Lasers 2001; 32 (3): 208-212.
56. Ciulla TA. Update on acute and chronic endophthalmitis. Ophthalmology 1999; 106: 2237-2238.